ARTICLE | Clinical News
IV elamipretide: Phase II data
June 27, 2016 7:00 AM UTC
Top-line data from the double-blind, dose-escalation, U.S. Phase II MMPOWER trial in 36 patients with mitochondrial myopathy associated with genetically confirmed mitochondrial disease showed that the...